Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artiss vs Staples for Burn Wound Skin Grafting
NCT00161759Phase 2Completed
- Sponsor
- Baxter
- Start
- Mar 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of calcium chloride in burn injury (2 arms), sponsored by Baxter. Primary endpoints: Percent Area of Hematoma/Seroma at 1 day, Questionable Graft Viability at 5 days and 1 more. Started Mar 2002; status: completed.
02
Drugs
calcium chloride
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT00161759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00161759.